Oh, No! FDA Delays Approval of Donanemab, Aducanumab, and Lecanemab: Discouraging Update
Truth, Lies & Alzheimer's04/03/24 • 17 min
Lisa shares an article that was published very recently (on 3/24/24) in The Guardian that updates us on the status of the drugs that have been touted as the “Alzheimer’s breakthrough”. In this episode, Lisa shares:
- Why these much-hyped drugs are now facing approval delays.
- Do their potentially harmful effects outweigh the benefits they were thought to deliver?
- What changed?
- Were the drug trials pure speculation or a collective desperation?
About the Host:
Author Lisa Skinner is a behavioral specialist with expertise in Alzheimer’s disease and related dementia. In her 30+year career working with family members and caregivers, Lisa has taught them how to successfully navigate the many challenges that accompany this heartbreaking disease. Lisa is both a Certified Dementia Practitioner and is also a certified dementia care trainer through the Alzheimer’s Association. She also holds a degree in Human Behavior.
Her latest book, “Truth, Lies & Alzheimer’s – Its Secret Faces” continues Lisa’s quest of working with dementia-related illnesses and teaching families and caregivers how to better understand the daunting challenges of brain disease. Her #1 Best-seller book “Not All Who Wander Need Be Lost,” was written at their urging. As someone who has had eight family members diagnosed with dementia, Lisa Skinner has found her calling in helping others through the struggle so they can have a better-quality relationship with their loved ones through education and through her workshops on counter-intuitive solutions and tools to help people effectively manage the symptoms of brain disease. Lisa Skinner has appeared on many national and regional media broadcasts. Lisa helps explain behaviors caused by dementia, encourages those who feel burdened, and gives practical advice for how to respond.
So many people today are heavily impacted by Alzheimer's disease and related dementia. The Alzheimer's Association and the World Health Organization have projected that the number of people who will develop Alzheimer's disease by the year 2050 worldwide will triple if a treatment or cure is not found. Society is not prepared to care for the projected increase of people who will develop this devastating disease. In her 30 years of working with family members and caregivers who suffer from dementia, Lisa has recognized how little people really understand the complexities of what living with this disease is really like. For Lisa, it starts with knowledge, education, and training.
Thanks for listening!
Thanks so much for listening to our podcast! If you enjoyed this episode and think that others could benefit from listening, please share it using the social media buttons on this page.
Do you have some feedback or questions about this episode? Leave a comment in the section below!
Subscribe to the podcast
If you would like to get automatic updates of new podcast episodes, you can subscribe to the podcast on Apple Podcasts or Stitcher. You can also subscribe in your favorite podcast app.
Leave us an Apple Podcasts review
Ratings and reviews from our listeners are extremely valuable to us and greatly appreciated. They help our podcast rank higher on Apple Podcasts, which exposes our show to more awesome listeners like you. If you have a minute, please leave an honest review on Apple Podcasts.
04/03/24 • 17 min
Truth, Lies & Alzheimer's - Oh, No! FDA Delays Approval of Donanemab, Aducanumab, and Lecanemab: Discouraging Update
Transcript
Hi, welcome to another brand new episode of the truth lies and Alzheimer's show. I'm Lisa Skinner, your host. And the information that I am bringing to you today is an update on some very controversial medications that we've been talking about. As a matter of fact, a couple of weeks ago, I shared another update with you on these newly approved drugs by the FDA. And since then, just a couple of days ago, there's been a new update on these drugs
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/truth-lies-and-alzheimers-220384/oh-no-fda-delays-approval-of-donanemab-aducanumab-and-lecanemab-discou-48064238"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to oh, no! fda delays approval of donanemab, aducanumab, and lecanemab: discouraging update on goodpods" style="width: 225px" /> </a>
Copy